# Stem Cell Ophthalmology Treatment Study II

> **NCT03011541** · NA · RECRUITING · sponsor: **MD Stem Cells** · enrollment: 500 (estimated)

## Conditions studied

- Retinal Disease
- Age-Related Macular Degeneration
- Retinitis Pigmentosa
- Stargardt Disease
- Optic Neuropathy
- Nonarteritic Ischemic Optic Neuropathy
- Optic Atrophy
- Optic Nerve Disease
- Glaucoma
- Leber Hereditary Optic Neuropathy
- Blindness
- Vision Loss Night
- Vision Loss Partial
- Vision, Low
- Retinopathy
- Maculopathy
- Macular Degeneration
- Retina Atrophy

## Interventions

- **PROCEDURE:** Arm 1

## Key facts

- **NCT ID:** NCT03011541
- **Lead sponsor:** MD Stem Cells
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03011541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03011541, "Stem Cell Ophthalmology Treatment Study II". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03011541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*